Article

You have free access to this content

Improving State Pain Policies: Recent Progress and Continuing Opportunities†

  1. Dr. Aaron M. Gilson PhD1,
  2. Mr. David E. Joranson MSSW2,
  3. Ms. Martha A. Maurer MSSW, MPH3

Article first published online: 31 DEC 2008

DOI: 10.3322/CA.57.6.341

Issue

CA: A Cancer Journal for Clinicians

CA: A Cancer Journal for Clinicians

Volume 57, Issue 6, pages 341–353, November/December 2007

Additional Information

How to Cite

Gilson, A. M., Joranson, D. E. and Maurer, M. A. (2007), Improving State Pain Policies: Recent Progress and Continuing Opportunities. CA: A Cancer Journal for Clinicians, 57: 341–353. doi: 10.3322/CA.57.6.341

Author Information

  1. 1

    Gilson is Associate Director for U.S. Policy Research, the Pain & Policy Studies Group, University of Wisconsin School of Medicine and Public Health, Madison, WI

  2. 2

    Joranson is Director and Distinguished Scientist, the Pain & Policy Studies Group, University of Wisconsin School of Medicine and Public Health, Madison, WI

  3. 3

    Maurer is Project Assistant, the Pain & Policy Studies Group, University of Wisconsin School of Medicine and Public Health, Madison, WI.

  1. †

    This article is available online at http://CAonline.AmCancerSoc.org

Publication History

  1. Issue published online: 31 DEC 2008
  2. Article first published online: 31 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (138K)

References

  • 1
    Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, 109th Cong, 1st Sess (2005) (testimony of Scott Gottlieb, MD, Deputy Commissioner for Medical and Scientific Affairs, Food and Drug Administration).
  • 2
    Goudas LC, Bloch R, Gialeli-Goudas M, et al. The epidemiology of cancer pain. Cancer Invest 2005; 23:182–190.
  • 3
    Stewart WF, Ricci JA, Chee E, et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003; 290:2443–2454.
  • 4
    Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain 1993; 52:319–324.
  • 5
    Letizia M, Creech S, Norton E, et al. Barriers to caregiver administration of pain medication in hospice care. J Pain Symptom Manage 2004; 27:114–124.
  • 6
    Gilson AM, Joranson DE. Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators. J Pain Symptom Manage 2001; 21:227–237.
  • 7
    Joranson DE, Gilson AM. Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J Am Pharm Assoc (Wash) 2001; 41:213–220.
  • 8
    American Academy of Pain Medicine, American Pain Society, and American Society of Addiction Medicine. Definitions Related to the Use of Opioids for the Treatment of Pain. Glenview, IL: AAPM, APS, ASAM; 2001.
  • 9
    Rinaldi RC, Steindler EM, Wilford BB, Goodwin D. Clarification and standardization of substance abuse terminology. JAMA 1988; 259:555–557.
  • 10
    Savage SR, Joranson DE, Covington EC, et al. Definitions related to the medical use of opioids: evolution towards universal agreement. J Pain Symptom Manage 2003; 26:655–667.
  • 11
    Furstenberg CT, Ahles TA, Whedon MB, et al. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the State of New Hampshire. J Pain Symptom Manage 1998; 15:335–349.
  • 12
    Hollen CJ, Hollen CW, Stolte K. Hospice and hospital oncology unit nurses: a comparative survey of knowledge and attitudes about cancer pain. Oncol Nurs Forum 2000; 27:1593–1599.
  • 13
    Lebovits AH, Florence I, Bathina R, et al. Pain knowledge and attitudes of healthcare providers: practice characteristic differences. Clin J Pain 1997; 13:237–243.
  • 14
    Morrison RS, Wallenstein S, Natale DK, et al. “We don't carry that”—failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 2000; 342:1023–1026.
  • 15
    Breitbart W, Passik S, McDonald MV, et al. Patient-related barriers to pain management in ambulatory AIDS patients. Pain 1998; 76:9–16.
  • 16
    Drayer RA, Henderson J, Reidenberg M. Barriers to better pain control in hospitalized patients. J Pain Symptom Manage 1999; 17:434–440.
  • 17
    Tolle SW, Tilden VP, Rosenfeld AG, Hickman SE. Family reports of barriers to optimal care of the dying. Nurs Res 2000; 49:310–317.
  • 18
    Cancer Pain Management Policy Review Group. American Cancer Society position statement on regulatory barriers to quality cancer pain management. Atlanta, GA: American Cancer Society; 2001.
  • 19
    Gilson AM, Maurer MA, Joranson DE. State policy affecting pain management: recent improvements and the positive impact of regulatory health policies. Health Policy 2005; 74:192–204.
  • 20
    National Association of Attorneys General. Improving End-of-Life Care: The Role of Attorneys General. Washington, DC: National Association of Attorneys General; 2003.
  • 21
    Tucker KL. Medical board corrective action with physicians who fail to provide adequate pain care. J Medical Licensure & Discipline 2001; 87:130–131.
  • 22
    Barrett K, Watson A. Physician perspectives on a pilot prescription monitoring program. J Pain Palliat Care Pharmacother 2005; 19:5–13.
  • 23
    Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 2004; 21:137–142.
  • 24
    Joranson DE, Gilson AM, Nelson JM. Perceived barriers to the use of Schedule II pain medications: A survey of health-care professionals in three states. Poster presented at: 17th Annual Meeting of the American Pain Society; November 5–8, 1998; San Diego, CA.
  • 25
    Von Roenn JH, Cleeland CS, Gonin R, et al. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993; 119:121–126.
  • 26
    Weinstein SM, Laux LF, Thornby JI, et al. Physicians' attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J 2000; 93:479–487.
  • 27
    American Alliance of Cancer Pain Initiatives. Statement on Intractable Pain Treatment Acts (IPTA). Madison, WI: AACPI; 2004.
  • 28
    Ferrell B, Virani R, Grant M, et al. Analysis of pain content in nursing textbooks. J Pain Symptom Manage 2000; 19:216–228.
  • 29
    Bookwalter TC, Rabow MW, McPhee SJ. Content on end-of-life care in major pharmacy textbooks. Am J Health Syst Pharm 2003; 60:1246–1250.
  • 30
    World Health Organization. Cancer pain relief and palliative care. Report of a WHO Expert Committee (WHO Technical Report Series, No. 804). Geneva, Switzerland: World Health Organization; 1990.
  • 31
    World Health Organization. HIV-AIDS. Palliative care. Geneva, Switzerland: World Health Organization; 2004.
  • 32
    International Narcotics Control Board. United Nations Report of the International Narcotics Control Board for 1989. Demand for and supply of opiates for medical and scientific needs. Vienna, Austria: United Nations; 1989.
  • 33
    International Narcotics Control Board. Report of the International Narcotics Control Board for 2004. New York, NY: United Nations; 2005.
  • 34
    Institute of Medicine Committee on Opportunities in Drug Abuse Research. Pathways of Addiction: Opportunities in drug abuse research. Washington, DC: National Academy Press; 1996.
  • 35
    Institute of Medicine Committee on Care at the End of Life. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997.
  • 36
    Institute of Medicine National Cancer Policy Board. Improving Palliative Care for Cancer. Washington, DC: National Academy Press; 2001.
  • 37
    Miaskowski C, Cleary J, Burney R, et al. Guideline for the management of cancer pain in adults and children. Glenview, IL: American Pain Society; 2005.
  • 38
    National Institutes of Health Consensus Development Program. Symptom Management in Cancer: Pain, Depression and Fatigue. Statement prepared following a National Institutes of Health State-of-the-Science Conference on Symptom Management in Cancer; July 15–17, 2002; Bethesda, MD.
  • 39
    Joranson DE, Gilson AM, Ryan KM, et al. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. Madison, WI: Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center; 2000.
  • 40
    Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. 2nd ed. Madison, WI: University of Wisconsin Comprehensive Cancer Center; 2003.
  • 41
    Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. 3rd ed. Madison, WI: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center; 2006.
  • 42
    Pain & Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card. Madison, WI: University of Wisconsin Comprehensive Cancer Center; 2003.
  • 43
    Pain & Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card. 2nd ed. Madison, WI: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center; 2006.
  • 44
    Controlled Substances Act, Title 21 USC §801(1) (1970).
  • 45
    National Conference of Commissioners on Uniform State Laws. Uniform Controlled Substances Act. Adopted at its Annual Conference Meeting in its Ninety-Ninth Year; July 13–20, 1990; Milwaukee, WI.
  • 46
    National Conference of Commissioners on Uniform State Laws. Uniform Controlled Substances Act. Adopted at its Annual Conference Meeting in its One-Hundred-and-Third Year; July 29-August 5, 1994; Chicago, IL.
  • 47
    Federation of State Medical Boards of the United States, Inc. Essentials of a Modern Medical Practice Act. 11th ed. Dallas, TX: Federation of State Medical Boards of the United States, Inc.; 2006.
  • 48
    Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain 2002; 18(suppl):S91–S98.
  • 49
    Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage 2002; 23:138–147.
  • 50
    Federation of State Medical Boards of the United States, Inc. Model Guidelines for the Use of Controlled Substances for the Treatment of Pain. Euless, TX: Federation of State Medical Boards of the United States, Inc.; 1998.
  • 51
    Federation of State Medical Boards of the United States, Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. Dallas, TX: Federation of State Medical Boards of the United States, Inc.; 2004.
  • 52
    Tucker KL. Treatment of pain in dying patients. N Engl J Med 1998; 338:1231.
  • 53
    Tucker KL. A piece of the puzzle: bringing accountability to failure to treat pain adequately. J Palliat Med 2003; 6:615–617.
  • 54
    Clark HW. Policy and medical-legal issues in the prescribing of controlled substances. J Psychoactive Drugs 1991; 23:321–328.
  • 55
    Dahl JL, Joranson DE, Weissman DE. The Wisconsin cancer pain initiative: a progress report. Am J Hospice Care 1989; 6:39–43.
  • 56
    Hill CS Jr. The negative effect of regulatory agencies on adequate pain control. Prim Care Cancer 1989; 11:47–51.
  • 57
    New York State Public Health Council. Breaking down the barriers to effective pain management. Recommendations to improve the assessment and treatment of pain in New York State. Albany, NY: New York State Department of Health; 1998.
  • 58
    Weissman DE, Joranson DE, Hopwood MB. Wisconsin physicians' knowledge and attitudes about opioid analgesic regulations. Wis Med J 1991; 90:671–675.
  • 59
    National Association of Attorneys General. Resolution Calling for a Balanced Approach to Promoting Pain Relief and Preventing Abuse of Pain Medications. Adopted at the National Association of Attorneys General Spring Meeting; March 17–20, 2003; Washington, DC.
  • 60
    United Nations Economic and Social Council. Treatment of Pain Using Opioid Analgesics; Resolution 2005-25. Report on the forty-eighth session of the Commission on Narcotic Drugs E/2005/28; March 19, 2004 and March 7–11, 2005; issued July 22, 2005; Vienna, Austria.
  • 61
    United Nations Economic and Social Council. Demand for and Supply of Opiates Used to Meet Medical and Scientific Needs. Resolution 2005–26. Report on the forty-eighth session of the Commission on Narcotic Drugs E/2005/28; March 19, 2004 and March 7–11, 2005; issued July 22, 2005; Vienna, Austria.
  • 62
    World Health Organization. Achieving Balance in National Opioids Control Policy: Guidelines for Assessment. Geneva, Switzerland: World Health Organization; 2000.
  • 63
    World Health Organization Executive Board. Cancer control: Report by the Secretariat. 114th Session. EB114/3. Geneva, Switzerland: World Health Organization; 2004.
  • 64
    Joranson DE, Gilson AM. Wanted: a public health approach to prescription opioid abuse and diversion. Pharmacoepidemiol Drug Saf 2006; 15:632–634.
    Direct Link:
  • 65
    American Cancer Society National Government Relations Department-Policy Research. Cancer Pain Management Advocacy Toolkit. Washington, DC: American Cancer Society; 2003.
View Full Article (HTML) Get PDF (138K)